These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17418547)

  • 1. [Increased incidence of invasive meningococcal disease in Seine-Maritime. The evolving epidemiology due to the B:14:P1.7,16 strain].
    Parent du Châtelet I; Taha MK; Sesboüé C; Rouaud P; Perrocheau A; Lévy-Bruhl D
    Arch Pediatr; 2007 Jun; 14(6):537-40. PubMed ID: 17418547
    [No Abstract]   [Full Text] [Related]  

  • 2. [Coverage of meningococcal infections by local health authorities in Seine-Maritime].
    Sesboüé C
    Arch Pediatr; 2007 Jun; 14(6):544-5. PubMed ID: 17391939
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epidemiology of meningococcal infections in children in Loire-Atlantique and neighbouring areas from 1997 to 2002].
    Courtin V; Liet JM; Prat M; Picherot G; Rozé JC
    Arch Pediatr; 2005 Mar; 12(3):330. PubMed ID: 15734132
    [No Abstract]   [Full Text] [Related]  

  • 4. [Norman epidemics: MenBvac vaccine].
    Floret D
    Arch Pediatr; 2007 Jun; 14(6):541-3. PubMed ID: 17446054
    [No Abstract]   [Full Text] [Related]  

  • 5. Emergence of new virulent Neisseria meningitidis serogroup C sequence type 11 isolates in France.
    Deghmane AE; Parent du Chatelet I; Szatanik M; Hong E; Ruckly C; Giorgini D; Lévy-Bruhl D; Alonso JM; Taha MK
    J Infect Dis; 2010 Jul; 202(2):247-50. PubMed ID: 20515410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged outbreak of B meningococcal disease in the Seine-Maritime department, France, January 2003 to June 2005.
    Rouaud P; Perrocheau A; Taha MK; Sesboué C; Forgues AM; Parent du Châtelet I; Levy-Bruhl D
    Euro Surveill; 2006 Jul; 11(7):178-81. PubMed ID: 16966800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of meningococcal disease in southern Brazil from 1995 to 2003, and molecular characterization of Neisseria meningitidis using multilocus sequence typing.
    Baethgen LF; Weidlich L; Moraes C; Klein C; Nunes LS; Cafrune PI; Lemos AP; Rios SS; Abreu MF; Kmetzsch C; Sperb AF; Riley LW; Rossetti ML; Zaha A
    Trop Med Int Health; 2008 Jan; 13(1):31-40. PubMed ID: 18290999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outbreak in France of Neisseria meningitidis B:15:P1.12 belonging to sequence type 1403.
    Grodet C; Dequin PF; Watt S; Lanotte P; de Gialluly C; Taha MK; Alonso JM; Quentin R; Goudeau A; Mereghetti L
    Clin Microbiol Infect; 2004 Sep; 10(9):845-8. PubMed ID: 15355418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An epidemic of meningococcal disease in children in North Norway in the 1970s and 1980s was dominated by a hypervirulent group B strain.
    Nordheim K; Hovland IH; Kristiansen BE; Kaaresen PI; Flaegstad T
    Acta Paediatr; 2018 Mar; 107(3):490-495. PubMed ID: 29080366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of pathogenic Neisseria meningitidis serogroup B serosubtypes in Malta: implications for introducing PorA based vaccines.
    Pace D; Cuschieri P; Galea Debono A; Attard-Montalto S
    Vaccine; 2008 Nov; 26(47):5952-6. PubMed ID: 18801401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005.
    Can Commun Dis Rep; 2007 Jun; 33(10):1-15. PubMed ID: 17691125
    [No Abstract]   [Full Text] [Related]  

  • 12. Meningococcal B vaccine: new drug. The only vaccine against some serogroup B meningococci.
    Prescrire Int; 2008 Jun; 17(95):95-7. PubMed ID: 18623907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serogroup B meningococcal disease during Hajj: preparing for the worst scenario.
    Khalil MK; Borrow R
    Travel Med Infect Dis; 2009 Jul; 7(4):231-4. PubMed ID: 19717106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of sepsis and meningitis caused by probable travel-related Neisseria meningitidis serogroup B infection: the first report of N. meningitidis ST-4893 in Japan.
    Nakayama A; Takahashi H; Ohkusa K; Yamanaka K; Shintani C; Hayakawa S; Ishii J; Watanabe H
    Jpn J Infect Dis; 2011; 64(1):61-2. PubMed ID: 21266758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningococcal disease--Canada, 1991.
    Can Dis Wkly Rep; 1991 Dec; 17(52):293. PubMed ID: 1843664
    [No Abstract]   [Full Text] [Related]  

  • 16. New Zealand's epidemic of meningococcal disease described using molecular analysis: implications for vaccine delivery.
    Dyet K; Devoy A; McDowell R; Martin D
    Vaccine; 2005 Mar; 23(17-18):2228-30. PubMed ID: 15755601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid diagnosis of meningococcal disease.
    Bourke TW; Fairley DJ; Shields MD
    Expert Rev Anti Infect Ther; 2010 Dec; 8(12):1321-3. PubMed ID: 21133654
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2002, through 31 December, 2003.
    Can Commun Dis Rep; 2006 Apr; 32(8):97-107. PubMed ID: 16685767
    [No Abstract]   [Full Text] [Related]  

  • 19. Morbidity, mortality and spatial distribution of meningococcal disease, 1974-2007.
    Howitz M; Lambertsen L; Simonsen JB; Christensen JJ; Mølbak K
    Epidemiol Infect; 2009 Nov; 137(11):1631-40. PubMed ID: 19327198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of meningococcal disease in India.
    Sinclair D; Preziosi MP; Jacob John T; Greenwood B
    Trop Med Int Health; 2010 Dec; 15(12):1421-35. PubMed ID: 21054695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.